Ultralife (ULBI) Price to Sales (2010 - 2026)

Ultralife has reported Price to Sales for 17 years, with the latest figure at 2.2 in Q2 2026.

• On a quarterly basis, Price to Sales fell 28.62% year-over-year to 2.2 in Q2 2026; TTM through Jun 2026 was 0.56, a 32.69% decrease from a year earlier, with the FY2025 full-year figure at 0.5, down 33.85% from the prior year.
• Price to Sales was 2.2 for Q2 2026 at Ultralife, down from 2.29 in the prior quarter.
• The five-year high for Price to Sales was 4.21 in Q3 2024, with the low at 1.72 in Q4 2022.
• Average Price to Sales over 5 years is 2.67, with a median of 2.42 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Price to Sales plunged 57.82% in 2022, then soared 124.31% in 2024.
• Over 5 years, Price to Sales stood at 1.72 in 2022, then jumped by 45.09% to 2.5 in 2023, then increased by 12.91% to 2.83 in 2024, then slumped by 30.45% to 1.97 in 2025, then grew by 11.77% to 2.2 in 2026.
• The last three Price to Sales figures came in at 2.2 (Q2 2026), 2.29 (Q1 2026), and 1.97 (Q4 2025), per Business Quant data.